Results
1 -
10 of
45
(Click
here to explore results)
The Discovery and Utility of Chemical Probes in Target Discovery, CHAPTER 8 Chemical Probes for Kinases . Xiaoyun Lu, Jeff B. Smaill, Ke Ding
, 2021
, Pages 182-213
Kinase Drug Discovery, Chapter 5 Kinase Mutations and Resistance in Cancer . Jack Andrew Bikker
, 2012
, Pages 126-160
Drug Design Strategies: Quantitative Approaches, Chapter 5 Contribution of Structure-Based Drug Design to the Discovery of Marketed drugs . Alexander A. Alex, David S. Millan
, 2012
, Pages 108-163
Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 7 Influence of Heteroaromatic Rings on ADME Properties of Drugs . Deepak Dalvie, Ping Kang, Cho-Ming Loi, Lance Goulet, Sajiv Nair
, 2010
, Pages 328-369
The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection . Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
Allosterism in Drug Discovery, CHAPTER 17 Allosteric Inhibition of Abl Kinase . Anna Lucia Fallacara, Silvia Schenone, Maurizio Botta
, 2017
, Pages 381-403
Kinase Drug Discovery: Modern Approaches, CHAPTER 11 The Importance of Kinase Mutations in Cancer Drug Discovery . Richard A. Ward, Frederick W. Goldberg
, 2019
, Pages 281-312
Orphan Drugs and Rare Diseases, Chapter 4 Treating Rare Diseases: Business Model for Orphan Drug Development . Cory Williams
, 2014
, Pages 83-111
Kinase Drug Discovery, Chapter 7 The Drug Discovery and Development of Kinase Inhibitors Outside of Oncology . A. J. Ratcliffe
, 2012
, Pages 218-243
Kinase Drug Discovery: Modern Approaches, CHAPTER 3 The Screening and Design of Allosteric Kinase Inhibitors . Peng Wu, Peter Dinér, Lennart Bunch
, 2019
, Pages 34-60